Home / Companies / HCG Manavata Cancer Centre

HCG Manavata Cancer Centre FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

HCG Manavata Cancer Centre has 0 FDA recalls, 3 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "HCG Manavata Cancer Centre" is on file.

What these totals cover: FDA records filed under the name "HCG Manavata Cancer Centre".

Latest inspection: Sep 27, 2023 · VAI

Summary

Record counts and when each FDA source was last refreshed
Records	Count	Last refreshed	Source as of	Status
Recalls	0	Nov 8, 2026	File dated Nov 3, 2026	Current
510(k) clearances	0	Nov 8, 2026	File dated Nov 2, 2026	Current
Inspections	3	Nov 14, 2026	Newest record Nov 5, 2026	Current
Compliance actions	0	Nov 2, 2026	Newest record Oct 29, 2026	Current

FDA record by year

HCG Manavata Cancer Centre's FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Year	Inspections	OAI	Warning letters	Recall records	Class I
2026	0	0	0	0	0
2025	0	0	0	0	0
2024	0	0	0	0	0
2023	1	0	0	0	0
2022	1	0	0	0	0
2021	0	0	0	0	0
2020	0	0	0	0	0
2019	1	0	0	0	0
2018	0	0	0	0	0
2017	0	0	0	0	0

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing HCG Manavata Cancer Centre as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check HCG Manavata Cancer Centre yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Recent FDA inspections

3 inspections from Sep 27, 2019 to Sep 27, 2023.

Date	Site	Product	Classification	FEI
Sep 27, 2023	Nashik, India	Drugs	Voluntary Action Indicated (VAI)	3015050454
Aug 6, 2022	Nashik, India	Drugs	Voluntary Action Indicated (VAI)	3015050454
Sep 27, 2019	Nashik, India	Drugs	Voluntary Action Indicated (VAI)	3015050454

NAI: No objectionable conditions or practices were found during the inspection.
VAI: Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI: Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

1 inspected site, newest inspection first.

Facility	Location	Inspections	Latest
FEI 3015050454	Nashik, India	3	Sep 27, 2023

HCG Manavata Cancer Centre and the FDA: common questions

Has HCG Manavata Cancer Centre received an FDA warning letter?

No FDA warning letter addressed to the name "HCG Manavata Cancer Centre" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has HCG Manavata Cancer Centre received an FDA Form 483?

FDA has not published a Form 483 for "HCG Manavata Cancer Centre" in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect HCG Manavata Cancer Centre?

The most recent FDA inspection on file ended Sep 27, 2023 at Nashik, India and was classified VAI. FDA has 3 inspections of HCG Manavata Cancer Centre on file.

Need more than this page shows? Ask about HCG Manavata Cancer Centre in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.